Full-Time

Senior Manager

Clinical Training and Development

Posted on 10/3/2025

Kyowa Kirin

Kyowa Kirin

1,001-5,000 employees

Global specialty pharma leveraging fermentation and antibodies

Compensation Overview

$155k - $170k/yr

Princeton, NJ, USA

Hybrid

Hybrid position requiring some in-office presence.

Category
Medical, Clinical & Veterinary (1)
Required Skills
Data Analysis
Google Cloud Platform
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree in Life Sciences, Nursing, Pharmacy, Instructional Design, Organizational Development
  • Advanced degree (Master’s, PharmD, or equivalent) in a related discipline is preferred, especially with a focus on Clinical Research, Education, or Training & Development
  • Certification in instructional design, adult learning, or training (e.g., ATD, CPLP, or equivalent) is a plus
  • Minimum of eight (8) years of progressive experience in clinical research, clinical operations, quality oversight, or related roles within the pharmaceutical, biotechnology, or CRO industry
  • Proven track record of leading learning and development initiatives within clinical development or clinical operations
  • Demonstrated experience applying adult learning methodologies and instructional design principles in a regulated environment
  • Experience in designing, implementing, and evaluating training programs for diverse, global audiences
  • Strong project management skills with the ability to manage multiple priorities and timelines in a global matrixed environment
  • Excellent interpersonal and communication skills, with the ability to collaborate effectively across functions, regions, and external partners
  • Proficient in MS Office Suite, especially PowerPoint and/or other presentation software for training purposes
  • Experience working with or within global teams and adapting training content to diverse cultural and regulatory needs
  • Familiarity with GCP, ICH guidelines, and global clinical regulatory frameworks
  • Digital content creation skills, including proficiency with eLearning authoring tools (e.g., Articulate 360, Adobe Captivate, Vyond, or similar)
  • Working knowledge of Learning Management Systems (LMS) for training administration and tracking
  • Strong critical thinking and problem-solving skills to assess training gaps and propose effective solutions
  • Ability to work and communicate effectively across different regions and functions within a global, multicultural environment
  • Skilled in developing and using training metrics and analytics to evaluate program effectiveness and drive improvements
  • High attention to detail and organizational skills, with the ability to manage complex documentation and compliance requirements.
Responsibilities
  • Lead the design and execution of a comprehensive, annual training program, project related training, and ad-hoc training needs within Global Clinical Operations, in collaboration with cross-functional partners to ensure alignment with business priorities and regulatory expectations.
  • Partner with line managers and cross-functional stakeholders to assess training and development needs for new hires and existing employees, including annual and skill enhancement requirements.
  • Design and develop engaging training materials by collaborating with subject matter experts (SMEs) across departments, regions, and external partners as needed.
  • Deliver effective training using a variety of instructional methods tailored to the audience and topic, ensuring comprehension and retention among relevant stakeholders.
  • Implement and monitor effectiveness checks, gather and analyze training metrics, and report trends and performance outcomes to line managers and senior leadership.
  • Determine when training requires translation and manage translation processes to ensure global accessibility and compliance.
  • Ensure all training records are accurately documented, maintained, and filed in accordance with company policies and regulatory requirements.
  • Represent the Clinical Operations Training on strategic initiatives and relevant team meetings, contributing subject matter expertise to support broader organizational goals.
  • Create or support the development of tools and materials needed by cross-functional teams, collaborating with SMEs to ensure consistency and quality.
  • Manage onboarding training for all new hires; manager offboarding and handovers of employees.
  • Stay informed and aligned with ongoing trends related to GCP and Clinical Operations to ensure ongoing learning and development.

Kyowa Kirin is a global specialty pharmaceutical company that develops medicines using fermentation and antibody technologies. Its products target areas like nephrology, oncology, and immunology, with therapies built from biologics and other drug modalities. The company emerged from a merger between Kyowa Hakko Kogyo and Kirin Pharma, combining Kyowa’s fermentation and microbiology expertise with Kirin’s pharma resources to create a worldwide focus on specialty drugs. Unlike broader drug companies, Kyowa Kirin concentrates on a defined set of indications and runs a research-and-development-led business that aims to deliver innovative treatments for patients in need.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1885

Simplify Jobs

Simplify's Take

What believers are saying

  • Libmeldy commercialization in MLD expands rare disease revenue streams globally.
  • Orchard pipeline programs in MPS, FTD, Crohn's disease address high unmet needs.
  • North Carolina manufacturing capacity supports cell and gene therapy market growth.

What critics are saying

  • Libmeldy reimbursement denial in UK, Germany, US collapses primary revenue driver.
  • Orchard pipeline failures in Phase 2/3 trials eliminate $478M acquisition rationale.
  • Gene therapy manufacturing delays at Sanford facility constrain supply and revenue ramp.

What makes Kyowa Kirin unique

  • 75+ years fermentation expertise underpins proprietary antibody and gene therapy platforms.
  • Orchard Therapeutics acquisition adds Libmeldy gene therapy for rare genetic diseases.
  • $530M Sanford biologics facility enables scaled manufacturing of advanced cell therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Company Match

Paid Vacation

Paid Sick Leave

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Hybrid Work Options

Pet Insurance

Tuition Assistance

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

-1%
Benzinga
Dec 15th, 2025
Link Cell Therapies raises $92M to advance CAR-T cancer treatments for solid and liquid tumors

Link Cell Therapies has emerged from stealth with $60 million in Series A funding led by Johnson & Johnson Innovation – JJDC, bringing total capital raised to $92 million. The South San Francisco–based oncology company is developing CAR-T therapies for solid and liquid tumours using proprietary logic-gating technology. The platform enables safe targeting of multiple antigens co-expressed on cancer cells whilst sparing healthy tissue. Co-founded by Dr Robbie Majzner and Dr Crystal Mackall at Stanford University in 2022, Link's lead programme, LNK001 for renal cell carcinoma, is on track for an IND application and Phase I trial in 2026. The Series A round included participation from founding investors Samsara BioCapital and Sheatree Capital, alongside new backers Bristol Myers Squibb, Kyowa Kirin and Wing Venture Capital.

FinSMEs
Mar 4th, 2025
Garuda Therapeutics Closes $50M Series A-1 Financing

Garuda Therapeutics, a Cambridge, MA-based hematopoietic stem cell (HSC) therapies company, raised $50M in Series A-1 funding

Cimeio Therapeutics
Dec 10th, 2024
Cimeio Therapeutics Announces Partnership with Kyowa Kirin to Develop Novel Cell Therapies

The partnership combines Cimeio's proprietary Shielded Cell and Immunotherapy (SCIP) platform with Kyowa Kirin's expertise in cellular therapies and underscores both companies' commitment to using emerging cell and gene therapy technologies to develop new ways to treat patients.

Business North Carolina
Nov 27th, 2024
Op/ed: Biotech's role in North Carolina's job-creation success

Kyowa Kirin, a Japanese global specialty pharmaceutical company, plans to invest more than $200 million in Sanford to build its first pharmaceutical manufacturing complex in North America, adding more than 100 new jobs.

World Pharmaceutical Frontiers
Jun 11th, 2024
Kyowa Kirin to establish new $530m biologics manufacturing plant in US

Japan-based Kyowa Kirin has unveiled its plans to invest $530m to build a new advanced biologics manufacturing facility in Sanford in the American state of North Carolina.

INACTIVE